The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utility of a general molecular screening program in patients with GU malignancies: The ProfiLER trial experience.
 
Armelle Vinceneux
Travel, Accommodations, Expenses - Astellas Oncology; Novartis; Pfizer; Sandoz
 
Guillaume Moriceau
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Takeda
 
Marianne Lorcet
Travel, Accommodations, Expenses - Amgen; Bayer; Janssen; MSD; Pierre Fabre; Sanofi
 
Mélodie Carbonnaux
Travel, Accommodations, Expenses - Pfizer
 
Philippe Alexandre Cassier
Honoraria - Amgen; AstraZeneca; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Innate Pharma (Inst); Janssen (Inst); Lilly (Inst); Loxo (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Netris Pharma; Novartis; Roche
 
Catherine Terret
No Relationships to Disclose
 
Christian Baudet
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Daniel Pissaloux
No Relationships to Disclose
 
Sylvie Chabaud
No Relationships to Disclose
 
Qing Wang
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Olivier Tredan
Consulting or Advisory Role - AstraZeneca; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Novartis; Pfizer; Roche
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Sylvie Negrier
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer
Research Funding - IPSEN (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA PHARMA; IPSEN; Novartis; Pfizer
 
Helen Jane Boyle
Consulting or Advisory Role - Amgen; Janssen; Novartis; Sanofi Pasteur
Travel, Accommodations, Expenses - Amgen; Janssen; Pfizer; Sanofi
 
Aude Flechon
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis